Last reviewed · How we verify
NCT06685432: OBESITY
The Effect of Motivational Interviewing on Body Weight and Dietary Habits in Young Adult Women: A Randomized Controlled Study
NA trial testing Diet in Weight Loss in 80 participants. Completed in 1 January 2023.
20 November 2022
Quick facts
| Lead sponsor | Sibel ERDEM |
|---|---|
| Phase | NA |
| Status | Completed |
| Study type | INTERVENTIONAL |
| Allocation | na |
| Design | single group |
| Masking | none |
| Primary purpose | treatment |
| Enrollment | 80 |
| Start date | 20 August 2021 |
| Primary completion | 20 November 2022 |
| Estimated completion | 1 January 2023 |
| Sites | 1 location across Turkey (Türkiye) |
Drugs / interventions tested
- Diet
Conditions studied
- Weight Loss — all drugs for Weight Loss →
- Obese Women — all drugs for Obese Women →
Sponsor
Sibel ERDEM
Who can join
Adults 19 to 50, female only, with Weight Loss or Obese Women. Patients with the condition only — healthy volunteers not accepted.
Sponsor's own description
The purpose of the study is to evaluate the effect of applying web-based motivational interviewing technique to slightly overweight/obese individuals on individuals' body weight loss and gaining healthy eating habits. Hypotheses: 1. The rate of decrease in body weight of individuals in the intervention group with motivational interviewing (MI) is higher than the control group. 2. Individuals in the intervention group with MI show more improvement in healthy eating behaviors than the control group. 3. The decrease in daily energy and fat intake of individuals in the intervention group with MI is higher than the control group. 4. The rate of vegetables and fruits in daily food consumption of individuals in the intervention group with MI is higher than the control group. All participants were interviewed one-on-one in the one-hour intervention group (n=40) and the control group (n=40) for a total of 6 times in two weeks for three months (12 weeks) in a 30-minute video conference environment. Depending on the participant in the intervention group that received motivational interviews, the interview period was extended if necessary.
Publications & conference data
No peer-reviewed publications indexed yet for this trial. Completed trials usually publish results within 12-18 months.
Verify or expand the search:
- PubMed search for NCT06685432
- Europe PMC full search
- ASCO Meeting Library
- ESMO Meeting Library
- bioRxiv preprints
- medRxiv preprints
- Google Scholar
Related trials
Other trials of Diet
Trials testing the same drug.
- NCT07533513 — Effects and Mechanisms of Dietary Carbohydrate Intake and Quality on Glucose and Lipid Metabolism · NA · not yet recruiting
- NCT07457827 — Effect of Low-Carbohydrate Versus Balanced Diets on Anthropometric Blood Pressure, ApoB, and hsCRP in Healthy Adults · NA · not yet recruiting
- NCT07388589 — Soluble and Osmotic Fibre (SOLOS) Diet for Constipation · not yet recruiting
- NCT07289672 — Food Limitations In Crohn's Disease and Ulcerative coliTis · NA · not yet recruiting
- NCT07262112 — Efficacy of Resistance Exercise and an Anti-Inflammatory Diet on Pain, Disease Activity, Functional Status, and Quality · NA · not yet recruiting
Other recruiting trials for Weight Loss
Currently open trials in the same condition.
- NCT06811324 — Effects of Tirzepatide on Muscle and Vascular Health in Obese Older Adults · Phase 2 · recruiting
- NCT07223983 — Semaglutide (SEMA) for Alcohol Use Disorder (AUD) After Metabolic and Bariatric Surgery (MBS) · Phase 1 · recruiting
- NCT07213466 — Individualized Pharmacological Approach to Obesity in Patients With Bipolar Disorder · Phase 4 · recruiting
- NCT06785064 — Optimizing an Extended Care Intervention to Promote Weight Loss Maintenance · NA · recruiting
- NCT07165431 — Effect of a Postbiotic Supplementation in Overweight and Obese Subjects: A Randomized Controlled Trial (PARABIOTICS-2). · NA · recruiting
Verify against primary sources
- ClinicalTrials.gov — authoritative US registry record
- WHO ICTRP — international registry index
- EU Clinical Trials Register
- Sponsor press releases (Google)
- Trial protocol + status: ClinicalTrials.gov NCT06685432 (US National Library of Medicine, public domain)
- Drug + disease cross-links: matched in real time against Drug Landscape's normalised drug + company + condition tables
- Sponsor: as reported to ClinicalTrials.gov by Sibel ERDEM
- Last refreshed: 11 May 2025
Drug Landscape aggregates and links these public records for informational use only. Always verify against the primary source before clinical or regulatory decisions. Canonical URL: https://druglandscape.com/trial/NCT06685432.
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing